Biological and clinical significance of immunological cell markers in leukemia.
D000293:Adolescent; D000782:Aneuploidy; D000911:Antibodies, Monoclonal; D000941:Antigens / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D002455:Cell Division; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D002904:Chromosomes, Human, 21-22 and Y; D004796:Clinical Enzyme Tests; D005260:Female; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology*; D007223:Infant; D007938:Leukemia / Q000175:diagnosis / Q000235:genetics / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000175:diagnosis / Q000235:genetics / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D010641:Phenotype; D011379:Prognosis; D012397:Rosette Formation
D000911:Antibodies, Monoclonal; D000941:Antigens; D000951:Antigens, Neoplasm; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007136:Immunoglobulins